About
Nionyx Bio develops a proprietary adeno-associated virus (AAV) capsid platform and gene therapy pipeline focused on precision treatments for renal diseases.
Explore Nionyx Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.